Диаскинтест® и Тигратест® ТВ: сравнительная характеристика и опыт применения в диагностике туберкулезной инфекции

1. Pai M., Denkinger C.M., Kik S.V., Rangaka M.X., Zwerling A., Oxlade O. et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin. Microbiol. Rev. 2014; 27(1): 3–20. DOI: 10.1128/CMR.00034-13

2. Pai M., Zwerling A., Menzies D. T-cell–based assays for the diagnosis of latent tuberculosis infection: an updated systematic review. Ann. Intern. Med. 2008; 149(3): 177–184. DOI: 10.7326/0003-4819-149-3-200808050-00241

3. Kahwati L.C., Feltner C., Halpern M., Woodell C.L., Boland E., Amick H.R. et al. Screening for latent tuberculosis infection in adults: updated evidence report and systematic review. JAMA 2016; 316(9): 970–983. DOI: 10.1001/jama.2016.10357

4. Slogotskaya L., Bogorodskaya E., Ivanova D., Sevostyanova T. Comparative sensitivity of the test with tuberculosis recombinant allergen, containing ESAT6-CFP10 protein, and Mantoux test with 2 TU PPD-L in newly diagnosed tuberculosis children and adolescents in Moscow. PLoS One 2018; 13(12): e0208705. DOI: 10.1371/journal.pone.0208705

5. Starshinova A., Zhuravlev V., Dovgaluk I., Panteleev A., Manina V., Zinchenko U. et al. A comparison of intradermal test with recombinant tuberculosis allergen (diaskintest) with other immunologic tests in the diagnosis of tuberculosis infection. Int. J. Mycobacteriol. 2018; 7(1): 32–39. DOI: 10.4103/ijmy.ijmy_17_18

6. Nikitina I.Y., Karpina N.L., Kasimceva O.V., Gergert V.Y., Ergeshov A., Lyadova I.V. Comparative performance of QuantiFERON-TB Gold versus skin test with tuberculosis recombinant allergen (Diaskintest) among patients with suspected pulmonary tuberculosis in Russia. Int. J. Infect. Dis. 2019; 86: 18–24. DOI: 10.1016/j.ijid.2019.06.014

7. Starshinova A., Dovgalyk I., Malkova A., Zinchenko Y., Pavlova M., Belyaeva E. et al. Recombinant tuberculosis allergen (Diaskintest®) in tuberculosis diagnostic in Russia (meta-analysis). Int. J. Mycobacteriol. 2020; 9(4): 335–346. DOI: 10.4103/ijmy.ijmy_131_20

8. Сенин А.М., Эйсмонт Н.В., Голубев Д.Н. Применение «Диаскинтеста» для оценки активности туберкулезного процесса у контингентов фтизиатрической службы с сочетанной ВИЧ-инфекцией. Вестник современной клинической медицины 2016; 9(4): 101–107.

(Senin A.M., Eismont N.V., Golubev D.N. Application of Diaskintest for evaluation of tuberculosis activity in patients with HIV infection. The Bulletin of Contemporary Clinical Medicine 2016; 9(4): 101–107. (In Russ.)).

9. Бородулина Е.А., Лебедева Н.О., Поваляева Л.В., Цыганков И.Л., Бородулин Б.Е. Туберкулинодиагностика при туберкулезе легких в сочетании с ВИЧ-инфекцией. Казанский медицинский журнал 2012; 93(4): 576–579.

(Borodulina E.A., Lebedeva N.O., Povalyaeva L.V., Tsygankov I.L., Borodulin B.E. Tuberculin diagnostics for pulmonary tuberculosis in combination with HIV infection. Kazan Medical Journal 2012; 93(4): 576–579. (In Russ.)).

10. Ding X., Du W., Liu Q., Tao L., Shao Y., Lu P. et al. Accuracy of ESAT6-CFP10 skin test compared with tuberculin skin test in a healthy population: a randomized, blind, parallel controlled phase III clinical study. BMC Infect. Dis. 2024; 24(1): 1479. DOI: 10.1186/s12879-024-10302-6

11. Getahun H., Matteelli A., Chaisson R.E., Raviglione M.. Latent Mycobacterium tuberculosis infection. N. Engl. J. Med. 2015; 372(22): 2127–2135. DOI: 10.1056/NEJMra1405427

12. Tsoi K.K., Wu W.K., Tam L.S., Lee N. Tam L., Lee N. et al. Effect of immunosuppressive therapy on interferon γ release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis. Thorax 2016; 71(1): 64–72. DOI: 10.1136/thoraxjnl-2015-207811

13. Park C.H., Park J.H., Jung Y.S. Impact of Immunosuppressive Therapy on the Performance of Latent Tuberculosis Screening Tests in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. J. Pers. Med. 2022; 12(3): 507. DOI: 10.3390/jpm12030507

14. Hamada Y., Gupta R.K., Matteelli A., Abubakar I., Rangaka M.X. Predictive performance of interferon-γ release assays and tuberculin skin tests. Lancet Infect. Dis. 2020; 20(12): 1371–1372. DOI: 10.1016/S1473-3099(20)30772-6

15. Ruhwald M., Aggerbeck H., Gallardo R.V., Hoff S.T., Villate J.I., Borregaard B. et al. Safety and efficacy of the C-Tb skin test for diagnosis of Mycobacterium tuberculosis infection: a phase 3 randomized controlled trial. Lancet Respir. Med. 2017; 5(4): 259–268. DOI:10.1016/S2213-2600(16)30436-2

16. Zenner D., Beer N., Harris R.J., Lipman M.C., Stagg H.R., van der Werf M.J. Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis. Ann. Intern. Med. 2017; 167(4): 248–255. DOI: 10.7326/M17-0609